R&D Sponsored Birmingham: The UK’s new epicentre of health innovation Birmingham has a rich history as a manufacturing and innovation powerhouse in the UK
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
